296 related articles for article (PubMed ID: 8053669)
1. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate.
Pogány G; Hernandez DJ; Vogel KG
Arch Biochem Biophys; 1994 Aug; 313(1):102-11. PubMed ID: 8053669
[TBL] [Abstract][Full Text] [Related]
2. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins.
Rada JA; Cornuet PK; Hassell JR
Exp Eye Res; 1993 Jun; 56(6):635-48. PubMed ID: 8595806
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycans and diseases of soft tissues.
Halper J
Adv Exp Med Biol; 2014; 802():49-58. PubMed ID: 24443020
[TBL] [Abstract][Full Text] [Related]
4. Immortalized, cloned mouse chondrocytic cells (MC615) produce three different matrix proteoglycans with core-protein-specific chondroitin/dermatan sulphate structures.
Kokenyesi R; Silbert JE
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):831-9. PubMed ID: 9581563
[TBL] [Abstract][Full Text] [Related]
5. The interactions of cartilage proteoglycans with collagens are determined by their structures.
Vynios DH; Papageorgakopoulou N; Sazakli H; Tsiganos CP
Biochimie; 2001 Sep; 83(9):899-906. PubMed ID: 11698112
[TBL] [Abstract][Full Text] [Related]
6. Beta ig-h3 interacts directly with biglycan and decorin, promotes collagen VI aggregation, and participates in ternary complexing with these macromolecules.
Reinboth B; Thomas J; Hanssen E; Gibson MA
J Biol Chem; 2006 Mar; 281(12):7816-24. PubMed ID: 16434404
[TBL] [Abstract][Full Text] [Related]
7. Increased diameters of collagen fibrils precipitated in vitro in the presence of decorin from various connective tissues.
Kuc IM; Scott PG
Connect Tissue Res; 1997; 36(4):287-96. PubMed ID: 9610887
[TBL] [Abstract][Full Text] [Related]
8. Proteoglycans in the human sclera. Evidence for the presence of aggrecan.
Rada JA; Achen VR; Perry CA; Fox PW
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1740-51. PubMed ID: 9286262
[TBL] [Abstract][Full Text] [Related]
9. Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan.
Douglas T; Heinemann S; Bierbaum S; Scharnweber D; Worch H
Biomacromolecules; 2006 Aug; 7(8):2388-93. PubMed ID: 16903686
[TBL] [Abstract][Full Text] [Related]
10. Interaction of heparin cofactor II with biglycan and decorin.
Whinna HC; Choi HU; Rosenberg LC; Church FC
J Biol Chem; 1993 Feb; 268(6):3920-4. PubMed ID: 8440685
[TBL] [Abstract][Full Text] [Related]
11. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan.
Wiberg C; Klatt AR; Wagener R; Paulsson M; Bateman JF; Heinegård D; Mörgelin M
J Biol Chem; 2003 Sep; 278(39):37698-704. PubMed ID: 12840020
[TBL] [Abstract][Full Text] [Related]
12. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M
J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246
[TBL] [Abstract][Full Text] [Related]
13. Independent modulation of collagen fibrillogenesis by decorin and lumican.
Neame PJ; Kay CJ; McQuillan DJ; Beales MP; Hassell JR
Cell Mol Life Sci; 2000 May; 57(5):859-63. PubMed ID: 10892350
[TBL] [Abstract][Full Text] [Related]
14. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix.
Wiberg C; Hedbom E; Khairullina A; Lamandé SR; Oldberg A; Timpl R; Mörgelin M; Heinegård D
J Biol Chem; 2001 Jun; 276(22):18947-52. PubMed ID: 11259413
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
Hildebrand A; Romarís M; Rasmussen LM; Heinegård D; Twardzik DR; Border WA; Ruoslahti E
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):527-34. PubMed ID: 8093006
[TBL] [Abstract][Full Text] [Related]
16. Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5.
Svensson L; Heinegård D; Oldberg A
J Biol Chem; 1995 Sep; 270(35):20712-6. PubMed ID: 7657652
[TBL] [Abstract][Full Text] [Related]
17. Catabolism of aggrecan, decorin and biglycan in tendon.
Rees SG; Flannery CR; Little CB; Hughes CE; Caterson B; Dent CM
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):181-8. PubMed ID: 10926842
[TBL] [Abstract][Full Text] [Related]
18. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
[TBL] [Abstract][Full Text] [Related]
19. Distinct secondary structures of the leucine-rich repeat proteoglycans decorin and biglycan. Glycosylation-dependent conformational stability.
Krishnan P; Hocking AM; Scholtz JM; Pace CN; Holik KK; McQuillan DJ
J Biol Chem; 1999 Apr; 274(16):10945-50. PubMed ID: 10196174
[TBL] [Abstract][Full Text] [Related]
20. Molecular interaction of recombinant decorin and biglycan with type I collagen influences crystal growth.
Sugars RV; Milan AM; Brown JO; Waddington RJ; Hall RC; Embery G
Connect Tissue Res; 2003; 44 Suppl 1():189-95. PubMed ID: 12952196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
